Home › Research › Costs and economics
Cost of care for Alzheimer's disease and related dementias in the United States: 2016 to 2060
Nandi A, Counts N, Bröker J, Malik S, Chen S, Han R, Klusty J, Seligman B, Tortorice D, Vigo D, Bloom DE. npj Aging, 2024-02-08
Topic: Risk, prevention and care in population studies
Plain-language summary
This study projects that the total cost of caring for Americans with Alzheimer's and related dementias will grow enormously over the coming decades, driven by an aging population. Counting only paid, formal care, national costs are projected to rise from about $196 billion in 2020 to $1.4 trillion by 2060; including the value of unpaid family caregiving nearly triples that figure. The findings underscore how much of the true cost of dementia care is currently invisible because it is provided for free by family members.
What this study adds
Evidence grade: Moderate
This modelling study projects that the total cost of caring for Americans with Alzheimer's and related dementias will grow enormously over the coming decades, driven by an aging population. Its stated limit: Long-range (40-year) projections depend heavily on assumed inflation, prevalence, and care-pattern trends that carry substantial uncertainty, and per-patient cost inputs are derived from a single US survey subsample.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Nandi, A., Counts, N., Bröker, J., Malik, S., Chen, S., Han, R., et al. (2024). Cost of care for Alzheimer's disease and related dementias in the United States: 2016 to 2060. npj Aging.
Vancouver
Nandi A, Counts N, Bröker J, Malik S, Chen S, Han R, et al. Cost of care for Alzheimer's disease and related dementias in the United States: 2016 to 2060. npj Aging. 2024.
BibTeX
@article{nandi2024-dd2aca8e,
author = {Nandi, A. and Counts, N. and Bröker, J. and Malik, S. and Chen, S. and Han, R. and Klusty, J. and Seligman, B. and Tortorice, D. and Vigo, D. and Bloom, D. E.},
title = {{Cost of care for Alzheimer's disease and related dementias in the United States: 2016 to 2060}},
journal = {npj Aging},
year = {2024}
}
Built from the record alzhub holds for this paper, not looked up. This record has no DOI, so the citation leaves it out. Volume, issue and page numbers are not held in the record. The record names 11 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- 2016 per-patient formal care cost estimated at $28,078; informal care valued at $36,667 (replacement cost) or $15,792 (forgone wages)
- Aggregate formal-care-only costs projected to rise from $196 billion (2020) to $1.4 trillion (2060)
- Total cost including informal caregiving (replacement-cost method) projected to rise from $450 billion (2020) to $3.3 trillion (2060)
- Projections assume continuation of current demographic and cost-inflation trends over a 40-year horizon
Why it matters
This modelling study projects that the total cost of caring for Americans with Alzheimer's and related dementias will grow enormously over the coming decades, driven by an aging population. It underscores how much of the true cost of dementia care is currently invisible because it is provided for free by family members.
New to this subject? Start with our plain-English guide: Costs & economics →
Study details
- Study designmodelling
- Effect size2016 per-patient costs: formal care $28,078 (95% CI $25,893-$30,433), informal care $36,667 (replacement-cost) or $15,792 (forgone-wages); aggregate formal-care-only cost projected to rise from $196 billion (2020) to $1.4 trillion (2060); total cost including informal care (replacement method) from $450 billion (2020) to $3.3 trillion (2060)
- Evidence strengthModerate
Limitations
Long-range (40-year) projections depend heavily on assumed inflation, prevalence, and care-pattern trends that carry substantial uncertainty, and per-patient cost inputs are derived from a single US survey subsample.
How this study scored 48/100
Published in a peer-reviewed journal, and it is a computer model rather than new measurements. Scored zero for sample size, studied in people, randomized / blinded and indexed in PubMed because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 30 of the 62 points we could judge it on, which is 48 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (npj Aging) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 3 / 12 | A computer model rather than new measurements |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2024 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 0 / 2 | No PubMed ID and no DOI — scores zero (not stated in the record — scored 0) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 30 / 62 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 30 of the 62 points we could judge it on is 48 out of 100. |
| Total | 48 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Costs and economics from nearby years
Also in Costs and economics
21 studies in the library are filed under Costs and economics with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Costs and economics hub.